Compare NBTX & WBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | WBI |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2018 | 2025 |
| Metric | NBTX | WBI |
|---|---|---|
| Price | $27.39 | $28.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $54.44 | $36.50 |
| AVG Volume (30 Days) | 114.9K | ★ 499.0K |
| Earning Date | 09-24-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $525,553,000.00 |
| Revenue This Year | N/A | $71.53 |
| Revenue Next Year | $50.69 | $22.28 |
| P/E Ratio | ★ N/A | $158.00 |
| Revenue Growth | N/A | ★ 66.16 |
| 52 Week Low | $14.78 | $18.64 |
| 52 Week High | $57.14 | $36.89 |
| Indicator | NBTX | WBI |
|---|---|---|
| Relative Strength Index (RSI) | 31.35 | 27.72 |
| Support Level | $29.64 | $27.14 |
| Resistance Level | $35.38 | $27.57 |
| Average True Range (ATR) | 1.75 | 1.05 |
| MACD | -0.45 | -0.30 |
| Stochastic Oscillator | 0.55 | 2.20 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
WaterBridge Infrastructure LLC is an integrated, pure-play water infrastructure company with operations predominantly in the Delaware Basin, the prolific oil and natural gas basin in North America. It operates in the produced water infrastructure network in the United States through which it provides water management solutions to oil and natural gas E&P companies under long-term contracts, which include gathering, transporting, recycling, and handling produced water. It also operates two energy waste management facilities for the disposal of non-hazardous waste resulting from oil and gas E&P activities, branded under Desert Environmental. The transportation, treatment, and handling of produced water are crucial to oil and natural gas production.